BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis

Area of Science:

• Neuroscience
• Regenerative Medicine

Background:

• Remyelination is vital for CNS repair in demyelinating diseases like multiple sclerosis.
• Brain-enriched myelin-associated protein 1 (BCAS1) marks myelin-forming oligodendrocyte lineage cells.
• BCAS1+ oligodendrocytes are abundant in the cortex and crucial for regeneration.

Purpose of the Study:

• Investigate the role of BCAS1+ oligodendrocytes in cortical remyelination in multiple sclerosis.
• Compare responses in human tissue and experimental demyelination models.
• Understand oligodendrocyte behavior in acute and chronic disease stages.

Main Methods:

• Analysis of human cortical biopsy and autopsy tissue from multiple sclerosis patients.
• Comparison with experimental demyelination models in mice.
• Immunohistochemistry to identify BCAS1+ and MAG-expressing oligodendrocytes.
• Correlation with myeloid cell density.

Main Results:

• BCAS1+ oligodendrocytes in cortical lesions adopt an activated, myelin-forming morphology (expressing MAG) after demyelination.
• Activated BCAS1+ oligodendrocytes appear early during experimental demyelination, correlating with myeloid cells in human tissue.
• In chronic multiple sclerosis, quiescent BCAS1+ oligodendrocytes shift to mature myelin-maintaining cells, indicating limited replenishment.
• Perineuronal satellite oligodendrocytes are BCAS1+ and contribute to cortical remyelination.

Conclusions:

• BCAS1+ cells in the adult cortex are pre-differentiated oligodendrocytes that enable rapid myelin regeneration.
• Limited replenishment of BCAS1+ oligodendrocytes may underlie remyelination failure in chronic multiple sclerosis.
• These findings highlight BCAS1+ oligodendrocytes as key players in cortical repair and disease progression.